409 related articles for article (PubMed ID: 15114602)
1. Parenteral iron therapy options.
Silverstein SB; Rodgers GM
Am J Hematol; 2004 May; 76(1):74-8. PubMed ID: 15114602
[TBL] [Abstract][Full Text] [Related]
2. Parenteral iron use in the management of anemia in end-stage renal disease patients.
Bailie GR; Johnson CA; Mason NA
Am J Kidney Dis; 2000 Jan; 35(1):1-12. PubMed ID: 10620537
[TBL] [Abstract][Full Text] [Related]
3. Parenteral iron therapy: a single institution's experience over a 5-year period.
Laman CA; Silverstein SB; Rodgers GM
J Natl Compr Canc Netw; 2005 Nov; 3(6):791-5. PubMed ID: 16316614
[TBL] [Abstract][Full Text] [Related]
4. The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate.
Fishbane S; Kowalski EA
Semin Dial; 2000; 13(6):381-4. PubMed ID: 11130261
[TBL] [Abstract][Full Text] [Related]
5. Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.
Sane R; Baribeault D; Rosenberg CL
Pharmacotherapy; 2007 Apr; 27(4):613-5. PubMed ID: 17381390
[TBL] [Abstract][Full Text] [Related]
6. Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis.
Fishbane S; Wagner J
Am J Kidney Dis; 2001 May; 37(5):879-83. PubMed ID: 11325667
[TBL] [Abstract][Full Text] [Related]
7. Review of available intravenous iron preparations in hemodialysis.
Palmer K; Cameron K; Battistella M
CANNT J; 2013; 23(2):51-4; quiz 55-6. PubMed ID: 24069699
[No Abstract] [Full Text] [Related]
8. Comparative rates of adverse events with different formulations of intravenous iron.
Okam MM; Mandell E; Hevelone N; Wentz R; Ross A; Abel GA
Am J Hematol; 2012 Nov; 87(11):E123-4. PubMed ID: 22965928
[TBL] [Abstract][Full Text] [Related]
9. Should intravenous iron be upfront therapy for iron deficiency anemia?
Auerbach M
Pediatr Blood Cancer; 2011 Apr; 56(4):511-2. PubMed ID: 21298731
[No Abstract] [Full Text] [Related]
10. Addressing patient concerns about intravenous iron therapy.
Robbins KC
Nephrol Nurs J; 2003 Apr; 30(2):220-4, 258. PubMed ID: 12737000
[TBL] [Abstract][Full Text] [Related]
11. [Parenteral iron replacement].
Cynke E
Praxis (Bern 1994); 1997 May; 86(20):835-6. PubMed ID: 9312810
[No Abstract] [Full Text] [Related]
12. Acute injury with intravenous iron and concerns regarding long-term safety.
Bishu K; Agarwal R
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S19-23. PubMed ID: 17699372
[TBL] [Abstract][Full Text] [Related]
13. [Importance of the different i.v. iron generations for everyday medical practice].
Biggar P; Hahn KM
MMW Fortschr Med; 2013 Mar; 155 Suppl 1():18-24. PubMed ID: 23678667
[TBL] [Abstract][Full Text] [Related]
14. [Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease].
Potthoff SA; Münch HG
Dtsch Med Wochenschr; 2013 Jun; 138(24):1312-7. PubMed ID: 23737117
[TBL] [Abstract][Full Text] [Related]
15. The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
Anirban G; Kohli HS; Jha V; Gupta KL; Sakhuja V
Ren Fail; 2008; 30(6):629-38. PubMed ID: 18661414
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population.
Coppol E; Shelly J; Cheng S; Kaakeh Y; Shepler B
Ann Pharmacother; 2011 Feb; 45(2):241-7. PubMed ID: 21304025
[TBL] [Abstract][Full Text] [Related]
17. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.
Faich G; Strobos J
Am J Kidney Dis; 1999 Mar; 33(3):464-70. PubMed ID: 10070910
[TBL] [Abstract][Full Text] [Related]
18. Safety aspects of parenteral iron in patients with end-stage renal disease.
Sunder-Plassmann G; Hörl WH
Drug Saf; 1997 Oct; 17(4):241-50. PubMed ID: 9352960
[TBL] [Abstract][Full Text] [Related]
19. The Use of Parenteral Iron Therapy for the Treatment of Postpartum Anemia.
Nash CM; Allen VM
J Obstet Gynaecol Can; 2015 May; 37(5):439-442. PubMed ID: 26168105
[TBL] [Abstract][Full Text] [Related]
20. Parenteral iron dextran therapy: a review.
Burns DL; Mascioli EA; Bistrian BR
Nutrition; 1995; 11(2):163-8. PubMed ID: 7647482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]